A Study to Explore Pharmacokinetic Interaction Between Rilpivirine and Metformin in Healthy Participants

Completed · Phase 1

Conditions studied: Healthy Participants

In brief

The purpose of the study is to evaluate the effect of steady-state (constant concentration of medication in the blood) rilpivirine on pharmacokinetics (how a single dose of metformin is absorbed in the body, distributed within the body, and removed from the body) of a single dose of metformin, over time, in healthy adult participants.

Key facts

Study ID
NCT01719614
Run by
Janssen R&D Ireland
People needed
20
Starts
2012-10-01
Expected to finish
2013-01-01
Last updated by the study team
2014-03-06

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.